Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Liabilities from Discontinued Operations (2020)

Historic Liabilities from Discontinued Operations for Lexaria Bioscience (LEXX) over the last 1 years, with Q3 2020 value amounting to $250.0.

  • Lexaria Bioscience's Liabilities from Discontinued Operations changed N/A to $250.0 in Q3 2020 from the same period last year, while for Aug 2020 it was $250.0, marking a year-over-year change of. This contributed to the annual value of $250.0 for FY2020, which is N/A changed from last year.
  • Lexaria Bioscience's Liabilities from Discontinued Operations amounted to $250.0 in Q3 2020.
  • Lexaria Bioscience's 5-year Liabilities from Discontinued Operations high stood at $250.0 for Q2 2020, and its period low was $250.0 during Q2 2020.